Stem Cell Exosomes Shield Dog Sperm from Freezing Damage Better Than Seminal Plasma
MSC-derived exosomes significantly outperformed seminal plasma exosomes in protecting canine sperm motility, viability, and chromatin integrity during cryopreservation.
Summary
Researchers tested whether exosomes from mesenchymal stem cells (MSC-exo) or seminal plasma (SP-exo) could protect dog sperm during cryopreservation. Using a novel Aqueous Two-Phase System for exosome isolation, ejaculates from six dogs were divided into four groups before freezing. After thawing, MSC-exo-treated sperm showed significantly higher total motility (60.3%), progressive motility (22.1%), membrane integrity (66.9%), and viability (70.9%) compared to controls. Chromatin packaging integrity was also highest in the MSC-exo group at 91.3%. SP-exo groups showed modest improvements but did not match MSC-exo performance. Gene expression trends favored MSC-exo but did not reach statistical significance. These results position MSC-derived exosomes as a promising biological additive for canine sperm freezing protocols.
Detailed Summary
Sperm cryopreservation is a cornerstone of reproductive medicine and animal breeding, yet canine sperm is notoriously sensitive to freeze-thaw damage. Unlike in humans or livestock, no standardized freezing protocol exists for dogs, and the use of biologically derived additives to reduce cryoinjury remains largely unexplored. This study addresses that gap by investigating extracellular vesicles — specifically exosomes — as protective agents during canine sperm freezing.
Researchers isolated exosomes from two sources: adipose tissue-derived mesenchymal stem cells (MSC-exo) and canine seminal plasma (SP-exo). Notably, they employed the Aqueous Two-Phase System (ATPS), a novel isolation method not previously used in sperm cryopreservation research, potentially offering purer or more consistent exosome preparations. Ejaculates from six dogs were processed with Tris-based extenders and allocated to four groups — MSC-exo, 1.5% SP-exo, 2% SP-exo, and control — before cryopreservation.
Post-thaw analysis revealed striking advantages for the MSC-exo group across all major sperm quality parameters. Total motility reached 60.3% versus lower rates in other groups, and progressive motility, plasma membrane integrity, and viability were all significantly superior. Chromatin integrity — a key marker of sperm DNA health and fertilization potential — was highest in the MSC-exo group at 91.3%. SP-exo groups showed some benefit over the untreated control but were clearly inferior to MSC-exo.
Gene expression analysis did not yield statistically significant differences, though a positive trend was observed in the MSC-exo group, suggesting molecular-level protective mechanisms that may require larger samples to confirm.
These findings are meaningful beyond veterinary reproductive medicine. Exosome-based cryoprotection strategies could inform human fertility preservation and broader cell banking. Caveats include the small sample size of six dogs, the absence of fertilization outcome data, and the need to optimize MSC-exo concentration and characterization before clinical translation.
Key Findings
- MSC-exo group achieved 60.3% total sperm motility post-thaw, significantly higher than all other groups.
- Plasma membrane integrity reached 66.9% and viability 70.9% in MSC-exo-treated sperm.
- Chromatin packaging integrity was highest in MSC-exo group at 91.3%, indicating reduced DNA damage.
- SP-exo improved some parameters over control but was consistently outperformed by MSC-exo.
- Novel Aqueous Two-Phase System was used for exosome isolation, a first in sperm cryopreservation research.
Methodology
Six canine ejaculates were processed with Tris-based diluents and split into four groups: MSC-exo, 1.5% SP-exo, 2% SP-exo, and untreated control before cryopreservation. Exosomes were isolated using the Aqueous Two-Phase System method. Post-thaw assessment included CASA-based motility analysis, membrane and chromatin integrity assays, morphology evaluation, and gene expression profiling.
Study Limitations
The study used only six dogs, limiting statistical power and generalizability of gene expression findings. No in vivo fertilization or pregnancy outcome data were collected to confirm functional benefit. Optimal MSC-exo dosing, long-term storage stability, and scalability of the ATPS isolation method require further investigation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.